# Diagnostic Accuracy Of Seismocardiography for Coronary Artery Disease

Study · id `cardio:ct-nct06880120` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT06880120](<https://clinicaltrials.gov/study/NCT06880120>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT06880120

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease; Acute care and long-term living  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 1534 participants.

## Technical summary

Registry record NCT06880120. Allocation not applicable; no masking; primary purpose screening. Start 2021-05-19 (actual); primary completion 2021-10-19 (actual). Results not posted.

## Key facts

- Design: Interventional study; allocation not applicable; no masking; primary purpose screening
- Phase: Not applicable
- Enrolled: 1534 participants (enrolled count; ClinicalTrials.gov record NCT06880120, source copy `cardio:ctgov-nct06880120-2025-03-17`, retrieved 2026-10-26)
- Started: 2021-05-19 (actual) (ClinicalTrials.gov record NCT06880120, source copy `cardio:ctgov-nct06880120-2025-03-17`, retrieved 2026-10-26)
- Primary completion: 2021-10-19 (actual) (ClinicalTrials.gov record NCT06880120, source copy `cardio:ctgov-nct06880120-2025-03-17`, retrieved 2026-10-26)
- Completion: 2021-11-28 (actual) (ClinicalTrials.gov record NCT06880120, source copy `cardio:ctgov-nct06880120-2025-03-17`, retrieved 2026-10-26)
- Countries: Uzbekistan (ClinicalTrials.gov record NCT06880120, source copy `cardio:ctgov-nct06880120-2025-03-17`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct06880120-2025-03-17`, retrieved 2026-10-26)

## The registry's words

- Brief title: Diagnostic Accuracy Of Seismocardiography for Coronary Artery Disease
- Acronym: HF-CAD
- Condition: Coronary Artery Disease (CAD) (E.G., Angina, Myocardial Infarction, and Atherosclerotic Heart Disease (ASHD))
- Intervention (Device): Seismocardiography (SCG) and Gyrocardiography (GCG) Diagnostic Testing
- Lead sponsor: Heart Force Medical Inc.
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Angina pectoris (`cardio:angina-pectoris`)
- Registry condition terms include this condition: Coronary artery disease (`cardio:coronary-artery-disease`)
- Registry condition terms include this condition: Heart attack (myocardial infarction) (`cardio:myocardial-infarction`)

## Provenance

Content hash: eafb91116a8a8c24c2b460daedc7f8495eb48f8b6660f7155824aa07d5240cc4
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
